基本信息
views: 75

Bio
Dr K. M. CHAN graduated with BSc and received his PhD at the Department of Biochemistry, HKU. He then moved to Mayo Clinic (Rochester MN, USA) for postdoctoral training and obtained the Edward C. Kendall Research Fellowship in Biochemistry before rejoining HKU as Research Assistant Professor in June 2013. In February 2015 he joined the Department of Biomedical Sciences (BMS), City University of Hong Kong as a tenure-track Assistant Professor.
Research Interests
Dr Chan is interested in understanding 1) the role of epigenetics in regulating gene expression and human diseases and 2) how epigenetic information in maintained during cell division. It is well known that genetic information is encoded by the DNA sequence. However, DNA alone does not account for the complexity of the mammalian genome. Chromatin, comprising DNA, core histones and other regulatory proteins, regulates gene expression and maintains genome stability. Recent studies including ours have used the next generation sequencing technologies and the CRISPR-Cas9 approach to elucidate the mechanisms of mutant histones in the development of brain and bone cancers. We are currently focusing on identifying new cancer driving histone mutations and discovering therapeutics for these diseases using different animal models.
Research Interests
Dr Chan is interested in understanding 1) the role of epigenetics in regulating gene expression and human diseases and 2) how epigenetic information in maintained during cell division. It is well known that genetic information is encoded by the DNA sequence. However, DNA alone does not account for the complexity of the mammalian genome. Chromatin, comprising DNA, core histones and other regulatory proteins, regulates gene expression and maintains genome stability. Recent studies including ours have used the next generation sequencing technologies and the CRISPR-Cas9 approach to elucidate the mechanisms of mutant histones in the development of brain and bone cancers. We are currently focusing on identifying new cancer driving histone mutations and discovering therapeutics for these diseases using different animal models.
Research Interests
Papers共 53 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wang Peng, Shu Chen, Jingyu Ma,Wenjie Wei, Naixin Lin,Jinchao Xing,Wenjing Guo, Heying Li,Liang Zhang,Kuiming Chan,Andrew Yen,Guangyu Zhu,Jianbo Yue
Nature communicationsno. 1 (2025): 1917-1917
Jiaojiao Zheng,Siying Wang,Lei Xia, Zhen Sun,Kui Ming Chan,René Bernards,Wenxin Qin,Jinhong Chen,Qiang Xia,Haojie Jin
Signal transduction and targeted therapyno. 1 (2025): 35-35
Qi Jia, Xiaoxiao Sun, Haoyu Li, Jianglong Guo, Kongyan Niu,Kui Ming Chan,René Bernards,Wenxin Qin,Haojie Jin
Gutno. 5 (2025): 840-852
International journal of molecular sciencesno. 6 (2024)
Huiqi Tan, Mia Xinfang Miao, Rylee Xu Luo,Joan So,Lei Peng,Xiaoxuan Zhu,Eva Hin Wa Leung,Lina Zhu,Kui Ming Chan,Martin Cheung,Siu Yuen Chan
International journal of molecular sciencesno. 17 (2024)
BMC BIOLOGYno. 1 (2024)
Epigenetics & Chromatinno. 1 (2024): 1-14
10th International Conference on Higher Education Advances (HEAd’24) (2024)
Load More
Author Statistics
#Papers: 53
#Citation: 2729
H-Index: 21
G-Index: 41
Sociability: 6
Diversity: 3
Activity: 40
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn